Found: 2
Select item for more details and to access through your institution.
Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study.
- Published in:
- Rheumatology & Therapy, 2021, v. 8, n. 2, p. 903, doi. 10.1007/s40744-021-00305-z
- By:
- Publication type:
- Article
Lupoid sclerosis.
- Published in:
- Rheumatology International, 2010, v. 30, n. 4, p. 431, doi. 10.1007/s00296-009-1175-1
- By:
- Publication type:
- Article